|
US2020360627A1
|
|
Single-Use Nasal Delivery Device
|
|
WO2020142206A1
|
|
Nasal drug delivery device
|
|
KR20210034047A
|
|
Airway delivery of levodopa and dopa decarboxylase inhibitors for the treatment of Parkinson's disease
|
|
WO2019136308A1
|
|
Intranasal delivery of olanzapine by precision olfactory device
|
|
AU2019205327A1
|
|
Intranasal delivery of levodopa powder by precision olfactory device
|
|
CN111936140A
|
|
Intranasal delivery of dihydroergotamine through precision nasal device
|
|
EP3713628A1
|
|
Intranasal device with dip tube
|
|
CN111372635A
|
|
Intranasal device with access port
|
|
CN108601916A
|
|
In-line arrangement nasal delivery device
|
|
US2015100042A1
|
|
Muroid Family Nasal Device
|
|
US2016101245A1
|
|
Medical unit dose container
|
|
CA2835208A1
|
|
Nozzles for nasal drug delivery
|
|
EP3679971A1
|
|
Nasal drug delivery device
|
